lifescience

Indicon's Listup report highlights how lifescience start-ups represent 11.4% of the Italian ecosystem

Finnish start-up with offices also in Italy and Australia closes a EUR 19 million round to develop cancer treatments

Innovative Italian healthcare companies find support in the European organisation's initiatives

The exit has an initial value of USD 250 million, which may rise to USD 752.5 million, and will be finalised by the second half of 2025

The innovative exhibition Big as a Virus is a collaboration between CNR and IED and hosted by Milan's Museum of Natural History

The start-up develops technologies in the field of medical diagnostics in order to make access and management more effective

Biotech company developing innovative radiotherapies for the treatment of solid tumors completes raising to total of 18 million euros

The healthcare startup receives the investment from the business angels of Italian Angels for Growth and from Italians in VC Partners in addition to other funds and business angels

This is the first transaction for Indaco Venture Partners in the field of technology transfer, the startup is working on innovative treatments in the field of oncology

Entrepreneur Giovanni Battistini and investment expert Tiziana Marcuccio explain the opportunities of the sector and those of the US market for startups